Catherine M. Szyman
CIK 1438538 · Chief Executive Officer · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$11.52M
Companies
5
Total Filings
116
Lifetime Open-Market Net
-$46.57M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MASI | CEO | 8,674 | $179.95 | $1.56M | $0 | 5 | 2026-03-16 |
| Inari Medical, Inc. (NARI) Delisted | Director | 0 | $79.97 | $0 | $533.7K | 8 | 2025-02-19 |
| EW | CVP, Critical Care | 81,287 | $85.11 | $6.92M | -$42.15M | 88 | 2024-09-03 |
| OM | Director | 24,596 | $4.49 | $110.4K | $0 | 4 | 2023-05-31 |
| MDT | SrVP & Pres Diabetes | 36,521 | $80.20 | $2.93M | -$4.95M | 10 | 2014-03-21 |
Recent Filings · Page 9 of 12
116 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-06-14 | EW | Sell (S) | −1,474 | -$272.0K | EDGAR |
| 2019-05-15 | EW | Sell (S) | −1,474 | -$262.3K | EDGAR |
| 2019-05-14 | EW | Mixed | −440 | -$546.5K | EDGAR |
| 2019-05-10 | EW | Grant (A) | +1,850 | $0 | EDGAR |
| 2019-04-16 | EW | Sell (S) | −1,474 | -$283.0K | EDGAR |
| 2019-03-15 | EW | Sell (S) | −1,474 | -$264.0K | EDGAR |
| 2019-02-21 | EW | Sell (S) | −1,474 | -$259.9K | EDGAR |
| 2019-02-19 | EW | Tax (F) | −2,924 | -$519.8K | EDGAR |
| 2019-01-16 | EW | Sell (S) | −700 | -$108.5K | EDGAR |
| 2018-12-18 | EW | Sell (S) | −700 | -$113.9K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.